Patents Assigned to Xanthia Global Limited
  • Patent number: 9035775
    Abstract: The present invention provides a new non-invasive technique for organ, e.g., heart and lung, monitoring. In at least one embodiment of the invention, a subject is radiated with a non-harmful and relatively low power electromagnetic source diagnostic signal normally associated with a communications protocol such as, but not limited to a version of the IEEE 802.11(x) family of protocols in the 2.4, 3.6, or 5 GHz spectrum bands. After passing through the patient, a return signal is acquired from the patient and compared to the original source signal. The differences between the source and modified signals are then analyzed to monitor the heart, e.g., measure heart rate and detect defects within the heart, and the lung. For example, using Doppler Effect principles, heart rate and motion can be measured from the differences in frequency, phase, and/or wavelength between the source signal and the modified signal reflected back from the heart moving within the patient.
    Type: Grant
    Filed: February 25, 2010
    Date of Patent: May 19, 2015
    Assignee: Xanthia Global Limited
    Inventor: Kenneth Margon
  • Patent number: 8994536
    Abstract: The present invention provides a new non-invasive technique for organ, e.g., heart and lung, monitoring. In at least one embodiment of the invention, a subject is radiated with a non-harmful and relatively low power electromagnetic source diagnostic signal normally associated with a communications protocol such as, but not limited to a version of the IEEE 802.11(x) family of protocols in the 2.4, 3.6, or 5 GHz spectrum bands. After passing through the patient, a return signal is acquired from the patient and compared to the original source signal. The differences between the source and modified signals are then analyzed to monitor the heart, e.g., measure heart rate and detect defects within the heart, and the lung. For example, using Doppler Effect principles, heart rate and motion can be measured from the differences in frequency, phase, and/or wavelength between the source signal and the modified signal reflected back from the heart moving within the patient.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: March 31, 2015
    Assignee: Xanthia Global Limited
    Inventor: Kenneth Margon
  • Patent number: 8947237
    Abstract: The present invention utilizes an accelerometer (included within a wireless physiology monitoring device or as part of a separate device such as, but not limited to a smartphone, e.g., iPhone, or other mobile device) to link a patient with a separate medical data acquisition device such as a weight scale or a blood pressure monitor in order to collect and transmit a range of medical data associated with the user. The medical data acquisition device includes a vibration source for emitting a vibration at a predetermined or random frequency. When the acquisition device is activated, a vibration is transmitted from the through the patient and is detected by the accelerometer. The accelerometer then measures the particular frequency of vibration and transmits this information to a centralized monitoring unit (CMU). Based on the measured frequency, the CMU is able to know that the same patient wearing/holding the device is also the same patient using the data acquisition device.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: February 3, 2015
    Assignee: Xanthia Global Limited
    Inventors: Kenneth Margon, Gubbi Umesh Renukanand